lobbying_activities: 1694020

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1694020	8f21e8bb-bbed-48af-91e3-5bae9bd29c29	Q2	PHARMAVITE LLC	286074	PHARMAVITE LLC	2015	second_quarter	FOO	1) Adequate FDA funding to fully enforce DSHEA, inspect dietary supplement manufacturers, take enforcement action against clear violations of law and carryout other required regulatory activities 2) New Dietary Ingredient Guidance - prompt publication of second draft guidance of this document from FDA 3) Full implementation by DEA of HR/4771 and S2012 Designer Anabolic Steroid Control Act	HOUSE OF REPRESENTATIVES,SENATE		60000	0	0	2015-07-13T17:46:48.187000-04:00